Liveramp Holdings Inc
Change company Symbol lookup
Select an option...
RAMP Liveramp Holdings Inc
IFF International Flavors & Fragrances Inc
PNM PNM Resources Inc
ALB Albemarle Corp
AMBC Ambac Financial Group Inc
ASUR Asure Software Inc
MRK Merck & Co Inc
AMR Alpha Metallurgical Resources Inc
AAL American Airlines Group Inc
ADMS Adamas Pharmaceuticals Inc

Information Technology : IT Services | Small Cap Growth
Company profile

LiveRamp Holdings, Inc. is a technology company. The Company provide enterprise data connectivity platform that helps organizations to leverage customer data. Powered by core identity capabilities and a network, it enables companies and their partners to connect, control, and activate data to transform customer experiences. It enables organizations to access and leverage data across the applications they use to interact with their customers. The core component of its platform is the omnichannel, deterministic identity graph. The LiveRamp platform resolves a customer's data to consumer identifiers that represent real people in a way that protects consumer privacy. Its solution offers people-based marketing solutions, including onboarding, identity resolution, Safe Haven, analytics and measurement, and consent management.

Closing Price
Day's Change
-2.80 (-5.65%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Precipio shares soar 32% premarket after rapid COVID test becomes available on Amazon

7:42 am ET May 4, 2021 (MarketWatch)

Shares of microcap Precipio Inc. (PRPO), a specialty diagnostics company, soared 32% in premarket trade Tuesday, adding to gains of more than 170% on Monday, after the company said its COVID-19 rapid antibody test is now available on's (AMZN) business platform. The 20-minute test, which was awarded emergency use authorization from the U.S. Food and Drug Administration in December, can only be purchased by qualified medical point-of-care providers. "Physicians and other medical facilities may now purchase these items directly from Amazon, and receive them within 2 business days," the company said in a statement on Monday. The test can identify the presence of antibodies that have been developed from exposure to the coronavirus-borne illness, or from vaccination and show an immune response. "Antibodies are the body's natural biological response to an infection or vaccination, and their development begins the body's process of building immunity to protect against future infections," Precipio said in the statement. The stock has gained 139% in the year to date, while the S&P 500 has gained 11.6%.

-Ciara Linnane; 415-439-6400;


(END) Dow Jones Newswires

May 04, 2021 07:42 ET (11:42 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.